Industry News
-
Sarepta Therapeutics Announces EMBARK Study Part 2 Results
Jan 31 2025 -
NHS England to offer Casgevy for sickle cell disease patients
Jan 31 2025 -
Tessera Therapeutics Advances In Vivo Gene Therapy For SCD
Jan 30 2025 -
CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options
Jan 29 2025 -
IASO Bio Announces Acceptance of New Drug Application for Equecabtagene Autoleucel (FUCASO) by the Singapore Health Sciences Authority (HSA)
Jan 29 2025 -
Cartesian Therapeutics announces FDA agreement for new trial
Jan 28 2025 -
EQT Life Sciences leads USD 75 million Series B in Atalanta Therapeutics, a biotech firm developing treatments for epilepsy and Huntington’s disease
Jan 28 2025 -
Stealth faces another hurdle as FDA delays decision on Barth syndrome drug
Jan 24 2025 -
Biogen’s higher dose Spinraza under review by US and EU regulators
Jan 23 2025